Researchers
Zukić, Branka
Results 41-60 of 159
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | EXPLORING VARIATION IN ADHESION G PROTEIN-COUPLED RECEPTOR GENES: INSIGHTS FROM GENOMIC DATASETS OF PEDIATRIC RARE DISEASE CASES IN SERBIA | Pavlović, Đorđe | Conference Paper | Mp. category will be shown later |
| 2024 | CAN NUDT15 BE PHARMACOGENETIC OR PHARMACOTRANSRIPTOMIC MARKER FOR 6- MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN SERBIA | Ristivojević, Bojan | Conference Paper | Mp. category will be shown later |
| 2024 | Uticaj promotorskih varijanti gena za uridin-difosfat-glukuronoziltransferazu 1A1 na metabolizam bilirubina i značaj UGT1A1*28 varijante kao farmakogenetičkog markera | Vuković, Marija; Zukić, Branka | Book parts | Mp. category will be shown later |
| 2023 | Covid-19 disease severity associated with vitamin d related genetic Variants | Kotur, Nikola | Conference Paper | Mp. category will be shown later |
| 2023 | Pharmacogenomics and pharmacotranscriptomics of acute leukemia in children: a path to personalized medicine | Zukić, Branka | Conference Paper | Mp. category will be shown later |
| 2023 | Application of principal component analysis (PCA) and analytical hierarchy process (AHP) in analysis of articulatory characteristics of phonemes of children with 22q11.2 Deletion Syndrome | Drakulić, Danijela | Conference Paper | Mp. category will be shown later |
| 2023 | Genome-wide association analysis for severe COVID-19 in Serbian population | Zečević, Marko; Kotur, Nikola | Conference Paper | Mp. category will be shown later |
| 2023 | NUDT15 AS POTENTIAL MARKER FOR PHARMACOGENETIC-GUIDED 6-MERCAPTOPURINE THERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN SERBIA![]() | Ristivojević, Bojan | Conference Paper | Mp. category will be shown later |
| 2023 | Can pharmacogenetic variants in TPMT, MTHFR and SLCO1B1 genes be used as potential markers of outcome prediction in systemic sclerosis patients? | Jelovac, Marina | Conference Paper | Mp. category will be shown later |
| 2023 | In Silico analysis and prediction of novel pharmacogenomic markers of pediatric ALL treatment | Gašić, Vladimir | Conference Paper | Mp. category will be shown later |
| 2023 | Precision medicine and COVID-19: Importance of host genome profiling | Zukić, Branka | Conference Paper | Mp. category will be shown later |
| 2023 | The pharmacogenomics of vincristine-induced peripheral neuropathy in pediatric acute lymphoblastic leukemia patients in Serbia | Ristivojević, Bojan | Conference Paper | Mp. category will be shown later |
| 2023 | Germline Variants in Cancer Predisposition Genes in Pediatric Patients with Central Nervous System Tumors![]() | Jovanović, Aleksa | Article | 21M21 |
| 2023 | Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients? | Jelovac, Marina | Article | 21M21 |
| 2023 | Expression profiles of long non-coding RNA gas5 and microrna-222 in younger AML patients![]() | Pavlović, Đorđe | Conference Paper | Mp. category will be shown later |
| 2022 | Ekspresioni profil i prognostički značaj duge nekodirajuće RNK GAS5 i mikro RNK-222 u akutnoj mijeloidnoj leukemiji![]() | Tosic, Natasa | Conference Paper | Mp. category will be shown later |
| 2022 | Индивидуализација терапије код деце са акутном лимфобластном леукемијом - новооткривени генетички маркери![]() | Гашић, Владимир | Conference Paper | Mp. category will be shown later |
| 2022 | P403: PROGNOSTIC SIGNIFICANCE OF LONG NON-CODING RNA GAS5 AND MICRORNA-222 EXPRESSION PROFILES IN YOUNGER AML PATIENTS![]() | Pavlović, Ð.; Tošić, Nataša | Article | 21aM21a |
| 2022 | Ekspresioni obrazac duge nekodirajuće RNK GAS5 i mikroRNK- 222 kod mlađih pacijenata obolelih od AML![]() | Pavlović, Đorđe | Conference Paper | Mp. category will be shown later |
| 2022 | Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia | Gašić, Vladimir | Article | 21M21 |
